PADI4 and neoplasm: Such a combined tumor‐therapeutic strategy based on sonosensitizer‐mediated SDT and PAD4 inhibitor‐augmented immunotherapy offers a potent immune memory function, protecting against tumor rechallenge after eliminating the primary tumors.